SUMITOMO PHARMA CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 410 JPY | +2.50% |
|
+5.40% | -12.02% |
| Apr. 22 | Lull in Geopolitical Tensions Lifts Asian Stock Markets | MT |
| Apr. 17 | Jefferies Adjusts Sumitomo Pharma’s Price Target to 420 Yen From 520 Yen, Keeps at Hold | MT |
Presenter SpeechUnknown Executive (Executives)I would like to report on the first quarter resu...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Sumitomo Pharma Co., Ltd. (formerly Sumitomo Dainippon Pharma Co., Ltd.) specializes in development, manufacturing and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceuticals (92.9%): for cardiovascular, gastrointestinal and infectious diseases, central nervous systems disorders and allergies treatment;
- other (7.1%): veterinary drugs, food additives, industrial chemical products, etc.
Net sales are distributed geographically as follows: Japan (39.8%), the United States (50.4%), North America (0.9%) and other (8.9%).
Sector
Pharmaceuticals
Calendar
2024-05-13
- Q4 2023 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
8
Last Close Price
410
JPY
Average target price
333.8
JPY
Spread / Average Target
-18.60%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -12.02% | 1.02B | |
| +25.83% | 653B | |
| +27.00% | 556B | |
| -6.76% | 354B | |
| +20.34% | 331B | |
| +3.00% | 296B | |
| +13.09% | 233B | |
| +5.46% | 201B | |
| -9.61% | 193B | |
| -6.26% | 144B |
- Stock Market
- Equities
- 4506 Stock
- News Sumitomo Pharma Co., Ltd.
- Transcript : Sumitomo Pharma Co., Ltd., Q1 2023 Earnings Call, Jul 29, 2022
